Both belong to a class of drugs that target multiple hormonal pathways to improve blood sugar control and promote weight loss, but they differ in their mechanisms, efficacy, and clinical applications
With the rapidly increasing use of semaglutides in our country, we know some patients who present with NAION will be on this drug, and to add to the challenge, diabetes, hypertension, cardiovascular disease and obesity, the common indications for prescribing a semaglutide, are also risk factors for NAION
This makes us a natural partner to support Ag-Tech initiatives like Innovation Venture, where Capital Ones expertise can be leveraged to begin developing solutions and elevate the next generation of leaders in the space alongside Delaware State University
Participants would administer 0.19, 0.37 or 0.74 ml to correspond to 0.25, 0.5 and 1 mg, respectively